Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 05, 2025, titled "Closure of USFDA inspection at Zydus injectable manufacturing plant at Jarod".
Press Release Sep 05 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Sep 04 2025
- Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market
- Press Release Sep 02 2025
- Press Release Aug 29 2025
- Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis
Later from Zydus Lifesciences
- Press Release Sep 15 2025
- Zydus Lifesciences Limited Press Release Sep 21 2025
- Press Release Sep 23 2025
- Press Release Oct 01 2025
- Press Release Oct 06 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences